- Report
- May 2025
- 267 Pages
Global
From €4396EUR$4,950USD£3,842GBP
- Report
- November 2025
- 185 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- February 2025
- 180 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- December 2025
- 220 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- March 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Report
- August 2025
- 147 Pages
Global
From €3508EUR$3,950USD£3,066GBP
- Report
- May 2025
- 114 Pages
Global
From €4219EUR$4,750USD£3,686GBP
- Report
- December 2025
- 421 Pages
Global
From €6212EUR$6,995USD£5,429GBP
- Report
- May 2025
- 100 Pages
Global
From €5284EUR$5,950USD£4,618GBP
- Report
- June 2025
- 182 Pages
Global
From €3997EUR$4,500USD£3,492GBP
- Report
- October 2025
- 199 Pages
Global
From €3149EUR$3,545USD£2,751GBP
€3498EUR$3,939USD£3,057GBP
- Report
- December 2025
- 282 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- December 2025
- 174 Pages
Global
From €5196EUR$5,850USD£4,540GBP
- Report
- April 2025
- 175 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Report
- March 2025
- 200 Pages
Global
From €3988EUR$4,490USD£3,485GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1421EUR$1,600USD£1,242GBP
€1776EUR$2,000USD£1,552GBP
- Report
- May 2025
- 90 Pages
Global
From €3500EUR$4,222USD£3,165GBP
- Report
- December 2024
- 332 Pages
Global
From €3727EUR$4,197USD£3,257GBP
- Report
- November 2025
- 250 Pages
Global
From €3548EUR$3,995USD£3,100GBP
- Report
- November 2025
- 250 Pages
Global
From €3548EUR$3,995USD£3,100GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more